ImmuneRegen BioSciences Inks Strategic Collaboration With MPI Research
As per the agreement, MPI Research is expected to develop and perform preclinical, FDA-required safety studies and analytical research services in support of ImmuneRegen’s lead drug candidate, Homspera,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.